140
Participants
Start Date
April 20, 2022
Primary Completion Date
December 31, 2027
Study Completion Date
March 31, 2028
Non-Operative Pain Management
The non-operative treatment arm will receive analgesics, physical therapy and will remain non-weight bearing. This will consist in anti-inflammatory drugs daily for 8-12 weeks and supervised physical therapy at least twice a week over a period of 8 weeks. Subjects in the non-operative arm will be offered the opportunity to crossover to the operative arm (ARM 2) of the study if the subjects do not report symptomatic improvement within 3 months after entry in this study.
Operative treatment arm will undergo transtibial medial meniscus root repair within 3 weeks of enrollment
The operative treatment group (ARM 2) will be treated acutely with a transtibial medial meniscus root repair and will be non-weight bearing for 6 weeks as well. For ARM 1 subjects if no subjective improvement is seen at 3 months, crossover will be allowed to a transtibial medial meniscal root repair (acute operative pathway (ARM 2)
RECRUITING
Rush University Medical Center, Chicago
International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS)
UNKNOWN
Rush University Medical Center
OTHER